Xdemvy to treat Demodex blepharitis
Name: Xdemvy Indications: To treat Demodex blepharitis. Active Ingredient: Lotilaner Company: Tarsus Pharmaceuticals, Inc. Approval Date: 7/25/2023 More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217603s000lbl.pdf